Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model

被引:106
作者
Sander, Beate [1 ,2 ,3 ]
Nizam, Azhar [4 ]
Garrison, Louis P., Jr. [5 ]
Postma, Maarten J. [6 ]
Halloran, M. Elizabeth [5 ]
Longini, Ira M., Jr. [5 ]
机构
[1] Univ Hlth Network, Div Clin Decis Making & Hlth Care Res, Toronto, ON M5G 2C4, Canada
[2] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, THETA Toronto Hlth Econ & Technol Assessment Coll, Toronto, ON M5S 1A1, Canada
[4] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA
[5] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[6] Univ Groningen, Dept Pharm, Groningen, Netherlands
关键词
computer simulation; cost-benefit analysis; economics; human disease outbreaks; influenza; pharmaceutical models; theoretical; COST-EFFECTIVENESS; OSELTAMIVIR; COMPLICATIONS; VACCINATION; PREVENTION; CHILDREN; HEALTH; IMPACT;
D O I
10.1111/j.1524-4733.2008.00437.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
To project the potential economic impact of pandemic influenza mitigation strategies from a societal perspective in the United States. We use a stochastic agent-based model to simulate pandemic influenza in the community. We compare 17 strategies: targeted antiviral prophylaxis (TAP) alone and in combination with school closure as well as prevaccination. In the absence of intervention, we predict a 50% attack rate with an economic impact of $187 per capita as loss to society. Full TAP (FTAP) is the most effective single strategy, reducing number of cases by 54% at the lowest cost to society ($127 per capita). Prevaccination reduces number of cases by 48% and is the second least costly alternative ($140 per capita). Adding school closure to FTAP or prevaccination further improves health outcomes but increases total cost to society by approximately $2700 per capita. FTAP is an effective and cost-saving measure for mitigating pandemic influenza.
引用
收藏
页码:226 / 233
页数:8
相关论文
共 38 条
  • [31] Turner D., 2003, Health Technol Assess, V7, P1, DOI DOI 10.3310/HTA7350
  • [32] *US DEP ED, 2005, DIG STAT 2005
  • [33] *US DEP ED I ED SC, 2006, PROJ ED STAT 2015
  • [34] *US DEP HHS, 2005, HHS PAND INFL PLAN M
  • [35] *US DEP LAB, COMP COST TRENDS 200
  • [36] Effectiveness of oseltamivir in preventing influenza in household contacts - A randomized controlled trial
    Welliver, R
    Monto, AS
    Carewicz, O
    Schatteman, E
    Hassman, M
    Hedrick, J
    Jackson, HC
    Huson, L
    Ward, P
    Oxford, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (06): : 748 - 754
  • [37] Population-wide benefits of routine vaccination of children against influenza
    Weycker, D
    Edelsberg, J
    Halloran, ME
    Longini, IM
    Nizam, A
    Ciuryla, V
    Oster, G
    [J]. VACCINE, 2005, 23 (10) : 1284 - 1293
  • [38] Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups
    Yang, Y
    Longini, IM
    Halloran, ME
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2006, 55 : 317 - 330